ask="7.200"
ask_size="700"
average_daily_volume="56166"
bid="4.550"
bid_size="700"
book_value="5.078"
change="+0.385"
change_from_200_day_moving_average="-1.020"
change_from_50_day_moving_average="-0.050"
change_from_52_week_high="-8.155"
change_From_52_week_low="0.935"
change_in_percent="+9.145%"
close="4.595"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.058"
ebitda="-20.26M"
eps_estimate_current_year="-8.610"
eps_estimate_next_quarter="-0.800"
eps_estimate_next_year="-2.570"
ex_dividend_date="N/A"
float_shares="6404000"
high="4.847"
high_52_weeks="12.750"
last_trade_date="2/9/2017"
last_trade_price="4.595"
last_trade_size="100"
last_trade_time="3:59pm"
low="4.150"
low_52_weeks="3.660"
market_capitalization="61.71M"
moving_average_200_day="5.615"
moving_average_50_day="4.645"
name="Aeglea BioTherapeutics
Inc."
notes="N/A"
one_year_target_price="17.000"
open="4.150"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-18.172%"
percent_change_from_50_day_moving_average="-1.082%"
percent_change_from_52_week_high="-63.961%"
percent_change_from_52_week_low="+25.546%"
previous_close="4.210"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.829"
price_per_sales="11.385"
revenue="4.97M"
shares_outstanding="13430000"
short_ratio="1.420"
stock_exchange="NGM"
symbol="AGLE"
volume="353571"
weeks_range_52="3.660 - 12.750"
